- Home
- NXB vs PAVM Comparison
NXB vs PAVM Comparison
Compare NXB & PAVM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
N/A
Current Price
$1.97
HOLD
Current Price
$4.95
Company Overview
Basic Information| Metric | NXB | PAVM |
|---|---|---|
| Founded | N/A | 2014 |
| Country | | United States |
| Employees | 40 | 41 |
| Industry | Marine Transportation | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 49.2M | 43.1M |
| IPO Year | 2025 | N/A |
Fundamental Metrics
Financial Performance| Metric | NXB | PAVM |
|---|---|---|
| Price | $1.97 | $4.95 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $65.00 |
| AVG Volume (30 Days) | ★ 35.6K | 10.0K |
| Earning Date | N/A | 05-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $603.94 |
| Revenue Next Year | N/A | $33.16 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.79 | $0.21 |
| 52 Week High | $2.57 | $28.44 |
Technical Indicators
Market Signals| Indicator | NXB | PAVM |
|---|---|---|
| Relative Strength Index (RSI) | 46.06 | 45.81 |
| Support Level | N/A | $4.25 |
| Resistance Level | $2.40 | $6.56 |
| Average True Range (ATR) | 0.13 | 0.51 |
| MACD | -0.01 | -0.02 |
| Stochastic Oscillator | 38.02 | 31.26 |
Price Performance
Historical Comparison NXB
PAVM
About NXB NextBoat Inc. Common Stcok
NextBoat Inc focused on AI-powered technology platform designed to modernize and scale the world-wide pre-owned marine marketplace.
About PAVM PAVmed Inc.
PAVmed Inc is a multi-product, commercial-stage medical technology company organized to advance a broad pipeline of medical technologies from concept to commercialization. The company operates in a single segment as a medical technology company, with the following lines of business: Diagnostics, Medical Devices, and Digital Health. Its products are EsoGuard, EsoCheck, and the Veris Cancer Care Platform.